Here’s How Coronavirus/COVID-19 Could Impact Multiple Sclerosis Patients
source: pixabay.com

Here’s How Coronavirus/COVID-19 Could Impact Multiple Sclerosis Patients

According to a story from NeurologyLive, patients being treated for autoimmune diseases such as multiple sclerosis (MS) or myasthenia gravis could be at heightened risk of infection with coronavirus because…

Continue Reading Here’s How Coronavirus/COVID-19 Could Impact Multiple Sclerosis Patients
A Scientist Dedicated Her Life to Researching Huntington’s Disease Before Facing a Diagnosis Herself
source: pixabay.com

A Scientist Dedicated Her Life to Researching Huntington’s Disease Before Facing a Diagnosis Herself

According to a story from Yahoo News, Dr. Nancy Wexler spent around 20 years in Venezuela conducting pivotal research on a deadly rare genetic disorder: Huntington's disease. On Lake Maracaibo,…

Continue Reading A Scientist Dedicated Her Life to Researching Huntington’s Disease Before Facing a Diagnosis Herself
Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know
source: pixabay.com

Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know

According to a story from LocalHealthGuide, COVID-19 has continued to spread through the US and the lackluster government response suggests that it isn't going to be contained any time soon.…

Continue Reading Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know
The Future of Inflammatory Bowel Disease Treatment: A Personalized and Optimized Algorithm
source: pixabay.com

The Future of Inflammatory Bowel Disease Treatment: A Personalized and Optimized Algorithm

According to a story from Healio, Dr. Adam Cheifetz recently spoke about treatment for inflammatory bowel disease (IBD) at GUILD Conference 2020. He says that it is time for each…

Continue Reading The Future of Inflammatory Bowel Disease Treatment: A Personalized and Optimized Algorithm
Acthar Gel Reduces Proteinuria for IgA Nephropathy Patients in Pilot Study
source: pixabay.com

Acthar Gel Reduces Proteinuria for IgA Nephropathy Patients in Pilot Study

According to a story from Yahoo Finance, the biopharmaceutical company Mallinckrodt recently released findings from an open label pilot study which tested the impact of Acthar Gel (corticotropin injection) as…

Continue Reading Acthar Gel Reduces Proteinuria for IgA Nephropathy Patients in Pilot Study
Trial Testing Combination Treatment for Untreated Multiple Myeloma Ends in Disappointment
source: pixabay.com

Trial Testing Combination Treatment for Untreated Multiple Myeloma Ends in Disappointment

According to a story from businesswire.com, the Bristol Myers Squibb Company recently released the topline results from its phase 3 clinical trial. This study was testing a combination treatment consisting…

Continue Reading Trial Testing Combination Treatment for Untreated Multiple Myeloma Ends in Disappointment
Investigational Treatment for Rett Syndrome gets Rare Pediatric Disease Designation
source: pixabay.com

Investigational Treatment for Rett Syndrome gets Rare Pediatric Disease Designation

According to a story from Wapakoneta Daily News, the drug companies ACADIA Pharmaceuticals Inc. and Neuren Pharmaceuticals Limited have recently announced that its investigational product candidate trofinetide has earned Rare…

Continue Reading Investigational Treatment for Rett Syndrome gets Rare Pediatric Disease Designation
Company Developing Treatment for Osteogenesis Imperfecta Announces Successful FDA Phase 2 Wrap-up Meeting
source: pixabay.com

Company Developing Treatment for Osteogenesis Imperfecta Announces Successful FDA Phase 2 Wrap-up Meeting

According to a story from Financial Buzz, the biopharmaceutical company Mereo BioPharma Group plc recently announced that it has successfully concluded its Type B End-of-Phase 2 meeting with the US…

Continue Reading Company Developing Treatment for Osteogenesis Imperfecta Announces Successful FDA Phase 2 Wrap-up Meeting
Study Examines Neurological Differences in Cystinosis Patients
source: pixabay.com

Study Examines Neurological Differences in Cystinosis Patients

In a study published recently in the Orphanet Journal of Rare Diseases, a team of researchers identified distinct variations in the neuroanatomical and neuropsychiatric phenotypes of cystinosis patients. Phenotype refers to visible,…

Continue Reading Study Examines Neurological Differences in Cystinosis Patients
2020 Travel Grants from the Jack McGovern Coats’ Disease Foundation: Don’t Miss Out!
source: pixabay.com

2020 Travel Grants from the Jack McGovern Coats’ Disease Foundation: Don’t Miss Out!

The Jack McGovern Coats' Disease Foundation, a nonprofit patient organization committed to supporting critical disease research and raising disease awareness, is offering travel grants for recipients to attend the 2020…

Continue Reading 2020 Travel Grants from the Jack McGovern Coats’ Disease Foundation: Don’t Miss Out!